Care Home Finance: 2026 Market Outlook
Few corners of UK commercial property combine durable demand and operational complexity quite like the care sector, and that combination is what makes care home finance its own discipline rather than a footnote to ordinary commercial lending. An ageing population keeps filling beds, investors keep chasing the income, and lenders keep underwriting homes as trading businesses rather than bricks and mortar. This overview from Care Homes Finance sets out where the market sits in 2026: the scale of demand, the weight of investment capital, how a trading care home is underwritten, what funding costs across the capital stack, and where we think the next twelve months are heading. The deep angles, acquisition, development, refinance, owner-operator, distressed and CQC turnaround, bridging and portfolio, each have their own guide, and we signpost them as we go.
A note on regulation first. Commercial and trading finance for care homes is unregulated business lending, and we do not hold authorisation from the Financial Conduct Authority; where a transaction needs regulated advice, we refer it to a regulated firm. Everything below is market commentary and indicative banding, not a quote, an offer or financial advice.
Care home finance in 2026: where the market sits
The demographic case underneath the whole sector is unusually clear. The UK population aged 85 and over stood at 1.75 million in mid-2024, around 2.5% of the population, and is projected to roughly double to 3.6 million by mid-2049 (ONS, 2024-based national population projections). The old-age dependency ratio climbs alongside it, from 280 per 1,000 working-age people in mid-2024 toward 329 by mid-2049 (ONS, 2024-based): more older people, and proportionally fewer working-age people to fund and staff their care, is a structural tailwind for occupancy and fees.
Supply has not kept pace, and much of what exists is ageing. Carterwood has projected a shortfall approaching 277,000 market-standard elderly care home beds by 2026 against a 75-plus population nearing 7 million (Carterwood, 2025), driven as much by the obsolescence of older stock as by absolute bed numbers. LaingBuisson puts 44% of current capacity as not purpose built and the top ten providers at only around 18% of beds (LaingBuisson, 35th edition, 2025), so the market is both fragmented and short of modern stock. The whole-of-market value of residential care for older people was estimated at GBP 26.2 billion as at December 2024 (LaingBuisson, 35th edition, 2025).
How a care home is financed differently from ordinary property
A care home is not financed like a shop or a warehouse. It is financed as a specialist operating business that happens to sit inside a building. Lenders look first at the sustainable cash the home generates and the regulatory standing of the operation, then at the property.
That shows up most clearly in valuation. Care homes are usually valued on a going-concern (trading) basis that reflects the income the operation produces, which typically sits above the bricks-and-mortar (vacant possession) value (Construction Capital fact pack, 2026). The going-concern premium is what a lender is really lending against. A weak CQC rating, falling occupancy or an admissions embargo pushes the going-concern value toward, or to, bricks and mortar, and borrowing capacity falls with it. It is also why ownership can split into an op-co (the operating business) and a prop-co (the property), a structure we cover in the owner-operator and portfolio guides.
How lenders underwrite a trading care home (EBITDARM, occupancy, fee mix)
The headline profitability measure for the sector is EBITDARM: earnings before interest, tax, depreciation, amortisation, rent and management charges. Stripping out rent and management lets lenders compare homes across different ownership structures on a like-for-like basis. Sector profitability has been recovering: the average EBITDARM margin reached 30.1% of income in 2024/25, up around four percentage points year on year (Knight Frank, 2024/25), helped by a sharp fall in agency reliance, with agency costs in nursing homes dropping to 2.9% of staff costs from 6.8% the prior year (Knight Frank, 2024/25).
Three operating drivers sit alongside EBITDARM. Occupancy is the percentage of registered beds filled; average occupancy across private homes hit 88.7% in 2024/25, the highest since before the pandemic (Knight Frank, 2024/25), with lenders expecting stabilised homes around 85% to 90%-plus (Construction Capital fact pack, 2026). Fee mix is the split between self-pay and local-authority funded residents, and a stronger self-pay weighting supports more resilient earnings; private-pay fees grew 10% against 7% for local authority in 2024/25 (Knight Frank, 2024/25). Scale matters too: homes of 60-plus beds posted EBITDARM margins around 32.6% to 32.7% against 22.6% for homes under 40 beds (Knight Frank, 2024/25).
On structure, lenders typically look for debt service cover (DSC) of around 1.4x to 1.6x on stabilised EBITDARM (Construction Capital fact pack, 2026), expressed as EBITDARM divided by annual debt service. A registered manager in post, stable staffing and a maintainable trading history all feed appetite.
Why the CQC rating moves pricing and lender appetite
The Care Quality Commission rating is a core appetite and pricing driver, and the numbers explain why. EBITDARM margins track the rating directly: Outstanding homes averaged 31.3%, Good 30.8% and Requires Improvement 26.8% in 2024/25 (Knight Frank, 2024/25). A downgrade to Requires Improvement is associated with roughly four to five percentage points lower profitability, which flows straight into the going-concern valuation and the financeability of the home.
In practice, a Good or Outstanding rating supports the finest terms; Requires Improvement narrows appetite and widens the margin; and an Inadequate rating or an admissions embargo can push a deal into distressed or specialist-lender territory (Construction Capital fact pack, 2026). The distressed and turnaround end of this spectrum is a sibling angle in its own right, and the bridging guide covers carrying an embargoed asset toward stabilisation.
Specialist healthcare lenders versus challenger banks versus high-street banks
Three broad lender categories serve the sector, and matching the deal to the right one is most of the job. Specialist healthcare lenders run dedicated teams that underwrite on EBITDARM and going-concern value, and usually hold the deepest appetite for trading care homes, including first-time operators, development and turnaround (Construction Capital fact pack, 2026). Challenger banks compete strongly on stabilised, well-rated homes and experienced operators. High-street banks are generally the most conservative, focused on established operators with strong ratings, high occupancy and clear trading histories. We do not name individual lenders; appetite shifts case by case.
Operator track record sorts across that spectrum. Experienced multi-home operators access higher leverage and finer pricing, while first-time operators usually face lower leverage and tighter terms (Construction Capital fact pack, 2026), a distinction we return to in the acquisition and owner-operator guides.
Typical loan to value, term and pricing bands
Pricing is anchored to the Bank of England base rate, held at 3.75% since the December 2025 cut (Bank of England, June 2026). Because care home term debt is quoted as a margin over base or a reference rate, the held rate underpins 2026 affordability.
For acquisition and term debt, leverage is typically around 60% to 70% of going-concern value, with experienced operators reaching the upper end and first-time operators often capped nearer 50% to 60% with a larger deposit (Construction Capital fact pack, 2026). LTV is measured against going-concern value, not bricks and mortar, which is why trading strength changes how much can be borrowed. Development finance is usually sized around 60% to 70% of total cost and up to about 60% to 65% of gross development value, funded in drawdowns with interest often rolled up through build and stabilisation (Construction Capital fact pack, 2026). The pricing table above sets out the indicative all-in bands across the capital stack, expressed as commentary rather than offers. Arrangement fees typically run around 1% to 2% of the facility, and term facilities commonly carry early repayment charges within an initial period.
The investment market and the weight of capital
The demand story has pulled in serious investment capital. UK healthcare real estate investment topped GBP 12 billion in 2025, the highest annual total on record and around four times the prior five-year average (Savills, 2025 full year), though that all-healthcare figure was heavily inflated by US REIT activity. The senior housing and care home subset alone saw GBP 1.5 billion deployed in the first half, the strongest H1 in a decade (Savills citing MSCI, H1 2025). Appetite remains intense: 93% of healthcare investors surveyed were looking to deploy capital, holding over GBP 7.8 billion and more than 115,000 beds (CBRE, 2025 survey). On yields, prime South-East seniors housing held around 5.25% through Q3 2025 (Knight Frank, Q3 2025), with secondary and regional assets trading wider.
That capital is showing up as a real development pipeline. Construction Capital planning data, 2026, scanned 41,722 records across 112 councils and identified 311 care home relevant applications across 81 councils, with Leeds (13), Mansfield (10), Reigate and Banstead (10), Sandwell (10) and Sefton (10) most active. Recent filings include a detached 70-bed home in Gloucestershire and a 66-bed scheme in East Suffolk (Construction Capital planning data, 2026), the modern, purpose-built stock the Carterwood shortfall points to.
The twelve-month outlook for care home finance borrowers
Our read for the next twelve months is constructive but selective. The base rate held at 3.75% (Bank of England, June 2026) gives borrowers a stable pricing anchor after the 2025 cuts, and recovering margins, with the average EBITDARM margin at 30.1% and occupancy at 88.7% (Knight Frank, 2024/25), mean stronger homes present better than they have in years. We expect specialist healthcare lenders and challenger banks to keep competing hardest for well-rated, high-occupancy, self-pay-weighted homes run by experienced operators.
The dividing line will be quality. Homes with a Good or Outstanding CQC rating, stable staffing and a healthy going-concern premium should find finance on sensible terms; homes with a weak rating, thin occupancy or a heavy local-authority weighting will face narrower appetite and wider pricing. With supply short of modern stock and the 85-plus cohort on track to double (ONS, 2024-based), the long-run demand case is intact. The task for borrowers in 2026 is to present the trading story clearly and match the deal to the right lender.
Frequently asked questions
What is EBITDARM and why do care home lenders use it? EBITDARM is earnings before interest, tax, depreciation, amortisation, rent and management charges. Lenders use it because stripping out rent and management makes homes comparable across different ownership structures, and it is the cleanest measure of the cash a home actually generates. The sector average margin was 30.1% in 2024/25 (Knight Frank, 2024/25).
How much can I borrow against a trading care home? Acquisition and term leverage is typically around 60% to 70% of going-concern value, with experienced operators reaching the upper end and first-time operators often nearer 50% to 60% (Construction Capital fact pack, 2026). Because lending is against going-concern value rather than the empty building, trading strength directly changes how much is available.
Does the CQC rating really affect my finance terms? Yes. A Good or Outstanding rating supports the best appetite and pricing, while Requires Improvement narrows appetite and widens margin, and the data shows roughly four to five percentage points lower EBITDARM at Requires Improvement (Knight Frank, 2024/25), which feeds straight into valuation and borrowing capacity.
Where to go next
Whether you are buying your first home, funding a ground-up scheme, refinancing onto a better rate or building out a portfolio, the right structure starts with an honest read of the trading story and the right lender for it. For the deep guides on each route, and to talk through your own situation as market commentary rather than regulated advice, start at the Care Homes Finance homepage. We work across specialist healthcare lenders, challenger banks and high-street banks, and tell you plainly where a deal fits.